In SCLC-A (ASCL1-driven) cell lines, SLFN11 expression showed a bimodal distribution (45): (1) high peak population: SLFN11 was highly expressed and sensitive to cisplatin/PARPi. This evidence concerns the gene ASCL1 and small cell lung carcinoma.